Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Schibli

Showing results (161-170 of 301) with videos related to

Pageof 31
Sort By:
European Journal of Medicinal Chemistry|November 19, 2013
Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imagingAristeidis Chiotellis, Linjing Mu, Adrienne Müller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2025
Optimizing uPAR-targeting radiopeptides for improved tissue distribution: progress towards radionuclide therapyChristian Vaccarin, Darja Beyer, Jerome V Schmid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumorsAndrea Bettio, Michael Honer, Cristina Müller, et al.
Nuclear Medicine and Biology|August 17, 2011
The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapySilvia Lehenberger, Christoph Barkhausen, Susan Cohrs, et al.
Chimia|July 2, 2014
Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brainRoger Slavik, Daniel Bieri, Stjepko Cermak, et al.
Bioconjugate Chemistry|February 8, 2018
Reduced <sup>18</sup>F-Folate Conjugates as a New Class of PET Tracers for Folate Receptor ImagingSilvan D Boss, Cristina Müller, Klaudia Siwowska, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2014
Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in miceCristina Müller, Maruta Bunka, Stephanie Haller, et al.
Nuclear Medicine and Biology|June 22, 2015
Cyclotron production of (44)Sc: From bench to bedsideNicholas P van der Meulen, Maruta Bunka, Katharina A Domnanich, et al.
Scientific Reports|November 30, 2019
Alpha-PET for Prostate Cancer: Preclinical investigation using <sup>149</sup>Tb-PSMA-617Christoph A Umbricht, Ulli Köster, Peter Bernhardt, et al.
Theranostics|October 12, 2020
Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [<sup>177</sup>Lu]Lu-PP-F11NMichal Grzmil, Yun Qin, Carina Schleuniger, et al.
Pageof 31

Showing results (161-170 of 301) with videos related to

Sort By:
Pageof 31
European Journal of Medicinal Chemistry|November 19, 2013
Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imagingAristeidis Chiotellis, Linjing Mu, Adrienne Müller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2025
Optimizing uPAR-targeting radiopeptides for improved tissue distribution: progress towards radionuclide therapyChristian Vaccarin, Darja Beyer, Jerome V Schmid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumorsAndrea Bettio, Michael Honer, Cristina Müller, et al.
Nuclear Medicine and Biology|August 17, 2011
The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapySilvia Lehenberger, Christoph Barkhausen, Susan Cohrs, et al.
Chimia|July 2, 2014
Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brainRoger Slavik, Daniel Bieri, Stjepko Cermak, et al.
Bioconjugate Chemistry|February 8, 2018
Reduced <sup>18</sup>F-Folate Conjugates as a New Class of PET Tracers for Folate Receptor ImagingSilvan D Boss, Cristina Müller, Klaudia Siwowska, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2014
Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in miceCristina Müller, Maruta Bunka, Stephanie Haller, et al.
Nuclear Medicine and Biology|June 22, 2015
Cyclotron production of (44)Sc: From bench to bedsideNicholas P van der Meulen, Maruta Bunka, Katharina A Domnanich, et al.
Scientific Reports|November 30, 2019
Alpha-PET for Prostate Cancer: Preclinical investigation using <sup>149</sup>Tb-PSMA-617Christoph A Umbricht, Ulli Köster, Peter Bernhardt, et al.
Theranostics|October 12, 2020
Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [<sup>177</sup>Lu]Lu-PP-F11NMichal Grzmil, Yun Qin, Carina Schleuniger, et al.
Pageof 31